Clearstead Advisors’s Eikon Therapeutics EIKN Stock Holding History
Bought
Maintained
Sold
Other funds holding EIKN
Clearstead Advisors's EIKN Position: Q3 2026 in Review
Clearstead Advisors opened a new position in Eikon Therapeutics (EIKN) in Q3 2026: 10 shares worth $81. The stake represents ﹤0.01% of the portfolio and ranks #3286 among its holdings.
98 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.
- Clearstead Advisors held 10 shares of Eikon Therapeutics worth $81 as of Q3 2026.
- Eikon Therapeutics was a new Clearstead Advisors position in Q3 2026.
- Eikon Therapeutics made up ﹤0.01% of Clearstead Advisors's portfolio in Q3 2026, its #3286 holding.
- 98 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.
Based on Clearstead Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.